BriefCase vs Fibresolve (with PCCP)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BriefCase

by Aidoc

Fibresolve (with PCCP)

by Imvaria

AI Verdict

BriefCase and Fibresolve are both AI-powered solutions in medical imaging, but they serve distinct primary functions. BriefCase focuses on streamlining communication and collaboration for critical findings across various medical specialties, acting as a triage and notification system. In contrast, Fibresolve is a specialized diagnostic tool for lung fibrosis, specifically aiding in the non-invasive assessment and subtype classification of interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF).

Choose BriefCase if…

Choose BriefCase if your hospital or health system needs an AI-powered solution to streamline communication and prioritize critical medical imaging findings across various specialties like emergency medicine, neurology, and cardiology. It is ideal for accelerating workflow triage by flagging suspected pathologies such as intracranial hemorrhage, pulmonary embolism, and cervical spine fractures, ensuring urgent cases receive immediate attention and improving overall care team collaboration.

View BriefCase →

Choose Fibresolve (with PCCP) if…

Choose Fibresolve if your clinical practice specializes in pulmonology and radiology and requires an AI-driven diagnostic tool for earlier and more accurate diagnoses of lung fibrosis, specifically Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD). This tool is best suited for non-invasive assessment using standard chest CT scans, providing diagnostic subtype classification and adjunctive information to clinicians, especially before considering invasive testing.

View Fibresolve (with PCCP) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BriefCase	Fibresolve (with PCCP)
Pricing	Enterprise pricing starts at approximately $50,000 per site per year and scales modularly.	Contact vendor for pricing.
Deployment	Aidoc's aiOS™ platform integrates seamlessly into a facility’s existing IT infrastructure, including PACS, EHR, VNA, scheduling systems, and radiology worklists, using standard communication protocols (DICOM, HL7, FHIR). It can be set up in 2 to 3 weeks, with some implementations as fast as 24 hours for rapid and efficient deployment.	Cloud-based centralized service.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BriefCase	Fibresolve (with PCCP)
Name	BriefCase	Fibresolve (with PCCP)
Company	Aidoc Medical	Imvaria
Tagline	AI-driven communication and collaboration for critical medical imaging findings.	Pioneering AI-driven solutions for earlier, accurate diagnoses in lung disease.
Description	Aidoc's BriefCase is an FDA-cleared AI-powered communication and collaboration solution integrated into the Aidoc platform, designed to streamline the sharing of critical medical imaging findings among care teams.	IMVARIA is a health tech company pioneering AI-driven solutions that empower clinicians to make accurate diagnoses and prognoses at earlier stages of disease.
Categories	Clinical Decision Support & Reference, Radiology & Imaging AI	Clinical Decision Support & Reference, Radiology & Imaging AI
Specialties	Cardiology, Emergency Medicine, Neurology, Pulmonology, Radiology	Pulmonology, Radiology
Key Features	AI-driven critical finding detection (via Aidoc platform), Secure, real-time communication of findings, Customizable communication protocols, Automated follow-up tracking and reminders, Seamless integration with PACS, RIS, and EHR systems, Comprehensive audit trails for all communications, Prioritization of urgent cases for immediate attention, Mobile access for care team collaboration	AI-driven diagnostic tool for lung fibrosis, Non-invasive assessment of ILD and IPF, Analyzes standard chest CT scans, Provides diagnostic subtype classification, Offers adjunctive information for clinicians, Designed for integration-free workflow, FDA-authorized and Breakthrough-Designated, Associated with CPT billing codes by the AMA

Videos

Demos, reviews, and walkthroughs featuring BriefCase and Fibresolve (with PCCP).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does BriefCase integrate into our existing radiology and clinical workflows, and what is the depth of its EHR integration?

BriefCase is designed for seamless integration with PACS, RIS, and EHR systems, leveraging the Aidoc platform's AI to detect critical findings. It streamlines communication by pushing these findings and related discussions directly into existing workflows, ensuring care teams receive timely, actionable information.

Given that Fibresolve (with PCCP) is focused on lung fibrosis, how does its diagnostic accuracy and sensitivity compare to current manual methods for ILD and IPF assessment?

Fibresolve (with PCCP) is an AI-driven diagnostic tool specifically for lung fibrosis, analyzing standard chest CT scans to provide diagnostic subtype classification for ILD and IPF. It offers adjunctive information to clinicians, aiming to empower earlier and more accurate diagnoses than traditional manual assessments.

What is the learning curve for physicians and care teams to effectively use BriefCase, and what kind of support is provided during and after implementation?

BriefCase is designed to integrate into existing workflows, which can reduce the learning curve. Aidoc provides comprehensive support, including customizable communication protocols and automated follow-up tracking, to ensure effective adoption and ongoing use by care teams.

For a multi-site health system, what considerations should we be aware of when rolling out BriefCase across different hospitals or clinics?

BriefCase is designed for large hospitals and health systems, with custom enterprise pricing and integration requirements. Its architecture supports multi-site deployment, offering consistent AI-driven critical finding detection and communication protocols across various locations, with centralized management and audit capabilities.

How does Fibresolve (with PCCP) fit into a pulmonologist's existing diagnostic pathway for interstitial lung diseases, and what is its impact on time-to-diagnosis?

Fibresolve (with PCCP) provides non-invasive assessment of ILD and IPF by analyzing standard chest CT scans, offering diagnostic subtype classification. This adjunctive information aims to empower clinicians to make earlier and more accurate diagnoses, potentially reducing the time-to-diagnosis for lung fibrosis conditions.

Can we get references from existing customers who have successfully implemented BriefCase and seen measurable improvements in care team communication and patient outcomes?

Aidoc has over 500 hospitals globally using its platform, including BriefCase. They can likely provide customer references who have experienced improved communication, prioritization of urgent cases, and enhanced collaboration among care teams, leading to better patient outcomes.